Last reviewed · How we verify
BRCA1/2-mutated and HRD-positive advanced solid tumors
Approved treatments
Pipeline
- Olaparib Oral Product · Duke University — Phase 1
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- BRCA1/2-mutated and HRD-positive advanced solid tumors patent landscape — cliff calendar, originator estates, attackable patents
- BRCA1/2-mutated and HRD-positive advanced solid tumors treatment landscape brief
- BRCA1/2-mutated and HRD-positive advanced solid tumors treatment updates RSS
Frequently asked questions about BRCA1/2-mutated and HRD-positive advanced solid tumors
What new drugs are in development for BRCA1/2-mutated and HRD-positive advanced solid tumors?
1 pipeline drugs tracked. Top candidates: Olaparib Oral Product.
Related
- Treatment landscape: BRCA1/2-mutated and HRD-positive advanced solid tumors patent cliff · BRCA1/2-mutated and HRD-positive advanced solid tumors CI report
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing